BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yue H, Jiang HY. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: An immunohistochemical study. World J Gastroenterol 2005; 11(32): 5057-5060 [PMID: 16124066 DOI: 10.3748/wjg.v11.i32.5057]
URL: https://www.wjgnet.com/1007-9327/full/v11/i32/5057.htm
Number Citing Articles
1
Mitra Zabihi, Ramin Lotfi, Amir-Mohammad Yousefi, Davood Bashash. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunitiesJournal of Cancer Research and Clinical Oncology 2023; 149(4): 1585 doi: 10.1007/s00432-022-04135-6
2
H. Guo, Y. Lv, T. Tian, T. H. Hu, W. J. Wang, X. Sui, L. L. Jiang, Z. P. Ruan, K. J. Nan. Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinomaCarcinogenesis 2011; 32(12): 1897 doi: 10.1093/carcin/bgr220
3
Thomas P.J. Hofer, Marion Frankenberger, Karl J. Staples, Löms Ziegler-Heitbrock. Expression of p57-Kip2 in monocytes and macrophagesImmunobiology 2006; 211(6-8): 455 doi: 10.1016/j.imbio.2006.05.018
4
Soley Bayraktar, Caio M Rocha Lima. Emerging cell-cycle inhibitors for pancreatic cancer therapyExpert Opinion on Emerging Drugs 2012; 17(4): 571 doi: 10.1517/14728214.2012.739606
5
Pınar Atasoy, Erdal Yilmaz, Onder Bozdogan, Sebnem Ayva, Ertan Batislam. Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a)International Urology and Nephrology 2009; 41(1): 55 doi: 10.1007/s11255-008-9399-7
6
Jiang Wang, Anmin Chen, Fengjin Guo. Study on inhibition of growth of ACHN cells via shRNA expression vector-mediated cyclinE1 gene silencingChinese Journal of Clinical Oncology 2009; 6(1): 29 doi: 10.1007/s11805-009-0029-7
7
Lie-Fen Shyur, Shu-Hua Lee, Shang-Tzen Chang, Chiu-Ping Lo, Yueh-Hsiung Kuo, Sheng-Yang Wang. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathwaysPhytomedicine 2010; 18(1): 16 doi: 10.1016/j.phymed.2010.06.005
8
Rajamanickam Subapriya, Ramasamy Kumaraguruparan, Siddavaram Nagini. Expression of PCNA, cytokeratin, Bcl-2 and p53 during chemoprevention of hamster buccal pouch carcinogenesis by ethanolic neem (Azadirachta indica) leaf extractClinical Biochemistry 2006; 39(11): 1080 doi: 10.1016/j.clinbiochem.2006.06.013
9
Jianyang Wang, Hong Zhao, Jing Yu, Xin Xu, Wenyang Liu, Hao Jing, Ning Li, Yuan Tang, Yexiong Li, Jianqiang Cai, Jing Jin. MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapyBiomedicine & Pharmacotherapy 2019; 110: 646 doi: 10.1016/j.biopha.2018.11.080
10
Weizhen Ye, Georges Mairet-Coello, Emanuel DiCicco-Bloom. DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brainHistochemistry and Cell Biology 2007; 127(2): 195 doi: 10.1007/s00418-006-0238-6
11
Yohan Lee, Jason Liu, Shilpa Patel, Timothy Cloughesy, Albert Lai, Haumith Farooqi, David Seligson, Jun Dong, Linda Liau, Donald Becker, Paul Mischel, Soheil Shams, Stanley Nelson. Genomic Landscape of MeningiomasBrain Pathology 2010; 20(4): 751 doi: 10.1111/j.1750-3639.2009.00356.x
12
Chonji Fukumoto, Dai Nakashima, Atsushi Kasamatsu, Motoharu Unozawa, Tomomi Shida-Sakazume, Morihiro Higo, Katsunori Ogawara, Hidetaka Yokoe, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa. WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in miceOncoscience 2014; 1(12): 807 doi: 10.18632/oncoscience.101
13
Robert Roskoski. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugsPharmacological Research 2016; 107: 249 doi: 10.1016/j.phrs.2016.03.012
14
David A. Skalicky, James G. Kench, Davendra Segara, Maxwell J. Coleman, Robert L. Sutherland, Susan M. Henshall, Elizabeth A. Musgrove, Andrew V. Biankin. Cyclin E Expression and Outcome in Pancreatic Ductal AdenocarcinomaCancer Epidemiology, Biomarkers & Prevention 2006; 15(10): 1941 doi: 10.1158/1055-9965.EPI-06-0319
15
Amanda R. Duselis, Craig Obergfell, Jennifer A. Mack, Michael J. O'Neill, Quang K. Nguyen, Rachel J. O'Neill, Paul B. Vrana. Changes in cell cycle and extracellular matrix gene expression during placental development in deer mouse (Peromyscus) hybridsReproduction, Fertility and Development 2007; 19(5): 695 doi: 10.1071/RD07015
16
Yun Xiao, Xia Li, Yueying Yang, Yadong Wang, Shaoqi Rao. Cell cycle-dependent gene networks relevant to cancerProgress in Natural Science 2008; 18(8): 945 doi: 10.1016/j.pnsc.2008.03.003
17
Watcharin Loilome, Sasithorn Yooyuen, Nisana Namwat, Paiboon Sithithaworn, Anucha Puapairoj, Junko Kano, Masayuki Noguchi, Masanao Miwa, Puangrat Yongvanit. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk groupTumor Biology 2012; 33(6): 2289 doi: 10.1007/s13277-012-0491-3
18
Tomoaki Saito, Atsushi Kasamatsu, Katsunori Ogawara, Isao Miyamoto, Kengo Saito, Manabu Iyoda, Takane Suzuki, Yosuke Endo-Sakamoto, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa, Chih-Hsin Tang. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral AngiogenesisPLOS ONE 2015; 10(9): e0137923 doi: 10.1371/journal.pone.0137923
19
Önder Bozdoğan, Pinar Atasoy, Ertan Batislam, M Murad Başar, Halil Başar. Significance of p57Kip2 Down-Regulation in Oncogenesis of Bladder Carcinoma: An Immunohistochemical StudyTumori Journal 2008; 94(4): 556 doi: 10.1177/030089160809400418
20
Daguang Wang, Fei Ye, Yabin Sun, Wei Li, Hongyi Liu, Jing Jiang, Yang Zhang, Chengkui Liu, Weihua Tong, Ling Gao, Yezhou Sun, Weijia Zhang, Terry SeeToe, Peng Lee, Jian Suo, David Y. Zhang. Protein Signatures for Classification and Prognosis of Gastric CancerThe American Journal of Pathology 2011; 179(4): 1657 doi: 10.1016/j.ajpath.2011.06.010
21
N. Arora, M. P. Bansal, A. Koul. Azadirachta indica acts as a pro‐oxidant and modulates cell cycle associated proteins during DMBA/TPA induced skin carcinogenesis in miceCell Biochemistry and Function 2013; 31(5): 385 doi: 10.1002/cbf.2909
22
Marion Peyressatre, Camille Prével, Morgan Pellerano, May Morris. Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide InhibitorsCancers 2015; 7(1): 179 doi: 10.3390/cancers7010179
23
Judy Yan, Damu Tang. Proteins of the Nucleolus2013; : 275 doi: 10.1007/978-94-007-5818-6_12
24
Cong Zhou, Peng Zhang, Guang-chao Xu, Dong-ming Wu, Ru-yan Liu, Qi Zeng, Chun-ting Wang. RNA Interference of Biot2 Induces G1Phase Arrest and Apoptosis in Mouse Colorectal Cancer Cell LineOncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2015; 22(2): 93 doi: 10.3727/096504014X14146137738583